Palifermin-induced flexural hyperpigmentation: A clinical and histological study of five cases

British Journal of Dermatology

Volumn 159, Issue 5, 2008, Pages 1200-1203

  Sibelt, L A G ^a   Aboosy, N ^a   Van Der Velden, W J F M ^a   Blijlevens, N M A ^a   Blokx, W A M ^a   Seyger, M M B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Filaggrin; Flexural hyperpigmentation; Hypergranulosis; Keratinocyte growth factor; Palifermin; Skin

Indexed keywords

BUSULFAN; CARMUSTINE; CEFTAZIDIME; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FILAGGRIN; IDARUBICIN; MELPHALAN; PALIFERMIN; VALACICLOVIR;

ADULT; ARTICLE; AXILLA; CLINICAL ARTICLE; CLINICAL FEATURE; ERYTHEMA; FEMALE; FLEXURAL HYPERPIGMENTATION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOLOGY; HUMAN; HYPERPIGMENTATION; INGUINAL REGION; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL;

AXILLA; FEMALE; FIBROBLAST GROWTH FACTOR 7; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPERPIGMENTATION; MALE; MIDDLE AGED; STOMATITIS;

EID: 54249135949     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08816.x     Document Type: Article

References (16)

1. Rubin JS, Bottaro DP, Chedid M et al. Keratinocyte growth factor. Cell Biol Int 1995 19 : 399 411.
2. Spielberger R, Stiff P, Bensinger W et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004 351 : 2590 8.
3. Rosen LS, Abdi E, Davis ID et al. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. J Clin Oncol 2006 24 : 5194 200.
4. Scully C, Sonis S, Diz PD. Oral mucositis. Oral Dis 2006 12 : 229 41.
5. Blijlevens N, Sonis S. Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis. Ann Oncol 2007 18 : 817 26.
6. Keijzer A, Huijgens PC, van de Loosdrecht AA. Palifermin and palmar-plantar erythrodysesthesia. Br J Haematol 2007 136 : 856 7.
7. Diaz LB, Guhl G, Eguren MC et al. Flexural cutaneous eruption due to palifermin. Br J Haematol 2008 140 : 464 5.
8. Lane SW, Manoharan S, Mollee PN. Palifermin-induced acanthosis nigricans. Intern Med J 2007 37 : 417 18.
9. Oji V, Hautier JM, Ahvazi B et al. Bathing suit ichthyosis is caused by transglutaminase-1 deficiency: evidence for a temperature-sensitive phenotype. Hum Mol Genet 2006 15 : 3083 97.
10. Farrell CL, Rex KL, Kaufman SA et al. Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice. Int J Radiat Biol 1999 75 : 609 20.
11. Farrell CL, Rex KL, Chen JN et al. The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Prolif 2002 35 (Suppl. 1 78 85.
12. Guo L, Yu QC, Fuchs E. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J 1993 12 : 973 86.
13. Marchese C, Rubin J, Ron D et al. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J Cell Physiol 1990 144 : 326 32.
14. Bao S, Wang Y, Sweeney P et al. Keratinocyte growth factor induces Akt kinase activity and inhibits Fas-mediated apoptosis in A549 lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2005 288 : L36 42.
15. Wildhaber BE, Yang H, Teitelbaum DH. Keratinocyte growth factor decreases total parenteral nutrition-induced apoptosis in mouse intestinal epithelium via Bcl-2. J Pediatr Surg 2003 38 : 92 6.
16. Gibson RJ, Keefe DM, Clarke JM et al. The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer. Cancer Chemother Pharmacol 2002 50 : 53 8.